Related Experiment Video
Updated: Feb 12, 2026

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
Evaluation of 25% Poloxamer As a Slow Release Carrier for Morphine in a Rat Model
Nurul H Sulimai1, Jeff C Ko1, Yava L Jones-Hall2
1Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN, United States.
Abstract:
The objectives of this study were to evaluate poloxamer as a slow release carrier for morphine (M) and potential tissue irritation after subcutaneous poloxamer-morphine (PM) injection in a rat model. Based on the result of a previous in vitro work, 25% poloxamer, with and without morphine, and saline were administered in 14 rats' flanks. Blood for morphine concentrations was automatically sampled at multiple preprogrammed time points using the Culex™ unit for 48 h. Skin tissues from the injection sites were harvested and evaluated for histopathological changes. Following M or PM administration, it was determined that the half-life (t1/2) was significantly longer in the PM (5.5 ± 7.2 h) than M (0.7 ± 0.8 h) indicated a slow dissolution of poloxamer with morphine. The tmax was within 15 min and Cmax was approximately three times higher with M than with PM, reaching 716.8 (±153.7 ng/ml) of plasma morphine concentrations. There was no significant difference in total area under the curve and clearance of M versus PM. Histology inflammatory scores were similar between M, PM, and poloxamer but were significantly higher than saline control. We concluded that 25% poloxamer was capable of increasing the t1/2 of morphine, without a significant tissue irritation.
Insights
Poloxamer effectively extended morphine's half-life in rats, acting as a slow-release carrier. This formulation showed no significant tissue irritation, suggesting its potential for sustained drug delivery.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Biomaterials
Background:
- Morphine is a potent analgesic with a short duration of action.
- Developing sustained-release formulations is crucial for improving pain management and reducing dosing frequency.
Purpose of the Study:
- To assess poloxamer as a subcutaneous slow-release carrier for morphine.
- To evaluate potential tissue irritation associated with poloxamer-morphine injections in a rat model.
Main Methods:
- Subcutaneous injection of 25% poloxamer with or without morphine, and saline in rat flanks.
- Automated blood sampling for 48 hours to measure plasma morphine concentrations.
- Histopathological evaluation of skin tissues from injection sites.
Main Results:
- Poloxamer-morphine significantly increased morphine's half-life (5.5 ± 7.2 h) compared to morphine alone (0.7 ± 0.8 h).
- Morphine alone showed a higher peak concentration (Cmax) and faster time to peak (Tmax) than poloxamer-morphine.
- Histological inflammatory scores were comparable between morphine, poloxamer-morphine, and poloxamer groups, and significantly higher than saline control.
Conclusions:
- 25% poloxamer functions as a viable slow-release carrier for morphine.
- The poloxamer-morphine formulation demonstrated a prolonged drug release profile without causing significant tissue irritation in rats.
Related Concept Videos
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Energy-releasing Steps of Glycolysis
The first energy-releasing step—the 6th step of glycolysis...
Opioid Analgesics: Morphine and Other Natural Cogeners
Carrier Transport
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Gene Evolution - Fast or Slow?

